Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZNF384
|
ENSG00000126746.13 | zinc finger protein 384 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_6794533_6794684 | ZNF384 | 3127 | 0.104438 | 0.84 | 4.2e-03 | Click! |
chr12_6795222_6795473 | ZNF384 | 2388 | 0.124907 | 0.82 | 6.9e-03 | Click! |
chr12_6796733_6797867 | ZNF384 | 435 | 0.639178 | 0.79 | 1.2e-02 | Click! |
chr12_6795038_6795189 | ZNF384 | 2622 | 0.116665 | 0.77 | 1.5e-02 | Click! |
chr12_6796293_6796669 | ZNF384 | 1254 | 0.233619 | 0.74 | 2.3e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_64974327_64974564 | 3.77 |
ZNF92 |
zinc finger protein 92 |
135651 |
0.04 |
chr1_90161451_90162026 | 3.29 |
LRRC8C |
leucine rich repeat containing 8 family, member C |
63107 |
0.09 |
chr16_32127523_32127674 | 3.27 |
IGHV3OR16-9 |
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
50212 |
0.11 |
chr17_47895772_47896107 | 3.19 |
RP11-304F15.3 |
|
27333 |
0.12 |
chr6_37470020_37470409 | 3.08 |
CCDC167 |
coiled-coil domain containing 167 |
2516 |
0.3 |
chr2_90450046_90450260 | 3.07 |
CH17-132F21.1 |
Uncharacterized protein |
8048 |
0.25 |
chr9_70403075_70403226 | 2.99 |
IGKV1OR-3 |
immunoglobulin kappa variable 1/OR-3 (pseudogene) |
8060 |
0.23 |
chr2_90448870_90449043 | 2.77 |
CH17-132F21.1 |
Uncharacterized protein |
9245 |
0.25 |
chr19_14485268_14485436 | 2.76 |
CD97 |
CD97 molecule |
6616 |
0.16 |
chr7_142504889_142505163 | 2.66 |
PRSS3P2 |
protease, serine, 3 pseudogene 2 |
23895 |
0.15 |
chr1_181366766_181367066 | 2.59 |
CACNA1E |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
15322 |
0.3 |
chr14_104861166_104861551 | 2.52 |
ENSG00000222761 |
. |
6027 |
0.28 |
chr7_50429911_50430494 | 2.49 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
62957 |
0.12 |
chr3_153180294_153180533 | 2.45 |
ENSG00000207323 |
. |
8947 |
0.25 |
chr1_212429420_212429636 | 2.42 |
PPP2R5A |
protein phosphatase 2, regulatory subunit B', alpha |
29351 |
0.16 |
chr22_41999679_42000103 | 2.40 |
PMM1 |
phosphomannomutase 1 |
13997 |
0.11 |
chr15_37392008_37392372 | 2.39 |
MEIS2 |
Meis homeobox 2 |
104 |
0.91 |
chr2_90450699_90450979 | 2.38 |
CH17-132F21.1 |
Uncharacterized protein |
7362 |
0.25 |
chr14_61872843_61873172 | 2.33 |
PRKCH |
protein kinase C, eta |
15595 |
0.24 |
chr4_40219694_40220159 | 2.30 |
RHOH |
ras homolog family member H |
17962 |
0.21 |
chr13_25173363_25173605 | 2.28 |
ENSG00000211508 |
. |
9733 |
0.19 |
chr1_65342372_65342702 | 2.24 |
JAK1 |
Janus kinase 1 |
89650 |
0.08 |
chr9_92031645_92032185 | 2.23 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
1833 |
0.43 |
chr8_61693757_61693981 | 2.21 |
RP11-33I11.2 |
|
28296 |
0.21 |
chr1_100908166_100908711 | 2.21 |
RP5-837M10.4 |
|
43115 |
0.14 |
chr1_101587391_101587816 | 2.18 |
ENSG00000252765 |
. |
11106 |
0.2 |
chr1_203732630_203732922 | 2.17 |
LAX1 |
lymphocyte transmembrane adaptor 1 |
1528 |
0.35 |
chr6_130030571_130030821 | 2.17 |
ARHGAP18 |
Rho GTPase activating protein 18 |
674 |
0.78 |
chr5_172466689_172466840 | 2.17 |
ENSG00000207210 |
. |
12794 |
0.14 |
chr11_6768410_6768888 | 2.16 |
OR2AG2 |
olfactory receptor, family 2, subfamily AG, member 2 |
21637 |
0.11 |
chr10_42738803_42738954 | 2.16 |
ENSG00000264398 |
. |
8455 |
0.28 |
chr8_22396870_22397394 | 2.16 |
RP11-582J16.4 |
|
5786 |
0.12 |
chr14_52620798_52621075 | 2.15 |
NID2 |
nidogen 2 (osteonidogen) |
85224 |
0.08 |
chr5_66458385_66458781 | 2.14 |
MAST4 |
microtubule associated serine/threonine kinase family member 4 |
20321 |
0.24 |
chr10_8445439_8445646 | 2.12 |
ENSG00000212505 |
. |
253252 |
0.02 |
chr22_40719217_40719484 | 2.11 |
ADSL |
adenylosuccinate lyase |
23157 |
0.17 |
chr16_27244085_27244503 | 2.09 |
NSMCE1 |
non-SMC element 1 homolog (S. cerevisiae) |
105 |
0.96 |
chr7_50411715_50412132 | 2.08 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
44678 |
0.17 |
chr5_110564408_110564849 | 2.08 |
CAMK4 |
calcium/calmodulin-dependent protein kinase IV |
4844 |
0.26 |
chr2_90448067_90448218 | 2.07 |
CH17-132F21.1 |
Uncharacterized protein |
10059 |
0.24 |
chr6_42008817_42009180 | 2.03 |
CCND3 |
cyclin D3 |
7426 |
0.16 |
chr10_32619705_32619856 | 2.03 |
RP11-135A24.4 |
|
15647 |
0.13 |
chr2_42523029_42523463 | 2.03 |
EML4 |
echinoderm microtubule associated protein like 4 |
5147 |
0.28 |
chr3_151965668_151966177 | 2.03 |
MBNL1 |
muscleblind-like splicing regulator 1 |
19907 |
0.21 |
chr2_197126192_197126464 | 2.03 |
AC020571.3 |
|
1171 |
0.51 |
chr1_65343327_65343799 | 2.03 |
JAK1 |
Janus kinase 1 |
88624 |
0.08 |
chr1_28270612_28270863 | 2.02 |
SMPDL3B |
sphingomyelin phosphodiesterase, acid-like 3B |
9116 |
0.12 |
chr7_138730829_138731153 | 2.02 |
ZC3HAV1L |
zinc finger CCCH-type, antiviral 1-like |
10216 |
0.21 |
chr12_4082516_4082813 | 2.02 |
RP11-664D1.1 |
|
68278 |
0.12 |
chr3_56951565_56952044 | 2.02 |
ARHGEF3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
1305 |
0.52 |
chr17_47825562_47826034 | 2.01 |
FAM117A |
family with sequence similarity 117, member A |
15695 |
0.14 |
chr6_52848822_52849150 | 2.01 |
ENSG00000252106 |
. |
4933 |
0.15 |
chr6_112311435_112311966 | 2.00 |
WISP3 |
WNT1 inducible signaling pathway protein 3 |
63575 |
0.11 |
chr10_91375136_91375287 | 2.00 |
ENSG00000198997 |
. |
22625 |
0.15 |
chr6_510010_510533 | 1.99 |
RP1-20B11.2 |
|
13900 |
0.28 |
chr14_98071027_98071273 | 1.97 |
ENSG00000240730 |
. |
74640 |
0.13 |
chr7_24239460_24239669 | 1.96 |
AC004485.3 |
|
55774 |
0.12 |
chr2_205831288_205831552 | 1.96 |
PARD3B |
par-3 family cell polarity regulator beta |
420697 |
0.01 |
chr2_162099978_162100818 | 1.96 |
AC009299.2 |
|
7275 |
0.21 |
chr12_92793486_92793789 | 1.96 |
RP11-693J15.4 |
|
21670 |
0.18 |
chr2_114009637_114009821 | 1.95 |
ENSG00000189223 |
. |
1386 |
0.36 |
chr3_112178356_112178657 | 1.94 |
BTLA |
B and T lymphocyte associated |
39699 |
0.17 |
chr18_2969219_2969604 | 1.94 |
RP11-737O24.1 |
|
2395 |
0.24 |
chr12_12680030_12680376 | 1.94 |
DUSP16 |
dual specificity phosphatase 16 |
6144 |
0.26 |
chr20_50152104_50152573 | 1.93 |
NFATC2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
6920 |
0.29 |
chr6_139434683_139434834 | 1.92 |
HECA |
headcase homolog (Drosophila) |
21491 |
0.23 |
chr18_29606522_29606811 | 1.91 |
RNF125 |
ring finger protein 125, E3 ubiquitin protein ligase |
8331 |
0.16 |
chr10_11272508_11272772 | 1.91 |
RP3-323N1.2 |
|
59301 |
0.12 |
chr13_41350115_41350453 | 1.89 |
MRPS31 |
mitochondrial ribosomal protein S31 |
4975 |
0.19 |
chr11_64540838_64541180 | 1.89 |
SF1 |
splicing factor 1 |
4223 |
0.13 |
chr14_98654810_98655207 | 1.88 |
ENSG00000222066 |
. |
143079 |
0.05 |
chr4_48140359_48140728 | 1.87 |
TXK |
TXK tyrosine kinase |
4270 |
0.19 |
chr9_215482_215833 | 1.86 |
C9orf66 |
chromosome 9 open reading frame 66 |
236 |
0.73 |
chr17_40467183_40467619 | 1.86 |
STAT5A |
signal transducer and activator of transcription 5A |
9213 |
0.13 |
chr8_71544698_71545136 | 1.86 |
ENSG00000243532 |
. |
22201 |
0.12 |
chr2_197996623_197996912 | 1.85 |
ANKRD44 |
ankyrin repeat domain 44 |
9310 |
0.26 |
chr13_26547909_26548247 | 1.84 |
ENSG00000223158 |
. |
23119 |
0.19 |
chr2_91671477_91671656 | 1.83 |
IGKV1OR2-118 |
immunoglobulin kappa variable 1/OR2-118 (pseudogene) |
7521 |
0.32 |
chr14_24602109_24602417 | 1.83 |
FITM1 |
fat storage-inducing transmembrane protein 1 |
1004 |
0.24 |
chr7_50301242_50301499 | 1.83 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
42954 |
0.18 |
chr9_69787031_69787182 | 1.80 |
IGKV1OR-2 |
immunoglobulin kappa variable 1/OR-2 (pseudogene) |
9153 |
0.24 |
chr1_8594076_8594346 | 1.80 |
RERE |
arginine-glutamic acid dipeptide (RE) repeats |
8125 |
0.23 |
chr2_90449597_90449871 | 1.79 |
CH17-132F21.1 |
Uncharacterized protein |
8467 |
0.25 |
chr4_40228763_40229105 | 1.79 |
RHOH |
ras homolog family member H |
26970 |
0.19 |
chr15_30471500_30471800 | 1.79 |
ENSG00000221785 |
. |
34570 |
0.11 |
chr12_12626746_12626962 | 1.78 |
DUSP16 |
dual specificity phosphatase 16 |
47205 |
0.15 |
chr19_30202308_30202855 | 1.78 |
C19orf12 |
chromosome 19 open reading frame 12 |
3034 |
0.32 |
chr3_107695096_107695544 | 1.78 |
CD47 |
CD47 molecule |
81888 |
0.11 |
chr15_32651213_32651761 | 1.77 |
ENSG00000221444 |
. |
34186 |
0.1 |
chr14_61814853_61815190 | 1.77 |
PRKCH |
protein kinase C, eta |
412 |
0.87 |
chr5_130718609_130718935 | 1.76 |
CDC42SE2 |
CDC42 small effector 2 |
2527 |
0.42 |
chr4_109031503_109031852 | 1.75 |
LEF1 |
lymphoid enhancer-binding factor 1 |
55780 |
0.13 |
chr6_90306124_90306275 | 1.75 |
ANKRD6 |
ankyrin repeat domain 6 |
27487 |
0.15 |
chr8_64081885_64082139 | 1.75 |
YTHDF3 |
YTH domain family, member 3 |
798 |
0.72 |
chr7_106818278_106818489 | 1.74 |
HBP1 |
HMG-box transcription factor 1 |
1688 |
0.39 |
chr5_156616881_156617104 | 1.74 |
ITK |
IL2-inducible T-cell kinase |
9155 |
0.13 |
chr22_17701465_17701764 | 1.73 |
CECR1 |
cat eye syndrome chromosome region, candidate 1 |
1124 |
0.53 |
chr4_78720938_78721089 | 1.72 |
CNOT6L |
CCR4-NOT transcription complex, subunit 6-like |
19204 |
0.24 |
chr2_175446502_175446734 | 1.72 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
3699 |
0.2 |
chr21_30394997_30395296 | 1.71 |
USP16 |
ubiquitin specific peptidase 16 |
1804 |
0.22 |
chr1_118159727_118159980 | 1.71 |
FAM46C |
family with sequence similarity 46, member C |
11297 |
0.21 |
chr12_49871140_49871291 | 1.70 |
KCNH3 |
potassium voltage-gated channel, subfamily H (eag-related), member 3 |
61725 |
0.08 |
chr5_110568093_110568590 | 1.70 |
CAMK4 |
calcium/calmodulin-dependent protein kinase IV |
8557 |
0.23 |
chr6_35565906_35566057 | 1.70 |
ENSG00000212579 |
. |
53614 |
0.1 |
chr8_129733336_129733487 | 1.70 |
ENSG00000221351 |
. |
98629 |
0.09 |
chr4_109063134_109063335 | 1.69 |
LEF1 |
lymphoid enhancer-binding factor 1 |
24223 |
0.2 |
chr2_158273515_158274051 | 1.69 |
CYTIP |
cytohesin 1 interacting protein |
22143 |
0.2 |
chr15_61098968_61099119 | 1.68 |
RP11-554D20.1 |
|
42104 |
0.18 |
chr1_151027090_151027301 | 1.67 |
MLLT11 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11 |
3039 |
0.11 |
chr7_144508892_144509461 | 1.67 |
TPK1 |
thiamin pyrophosphokinase 1 |
23970 |
0.23 |
chr3_128013710_128014056 | 1.66 |
ENSG00000221067 |
. |
67125 |
0.11 |
chrX_19769765_19770052 | 1.66 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
4087 |
0.35 |
chr1_151793290_151793755 | 1.66 |
RORC |
RAR-related orphan receptor C |
5045 |
0.08 |
chr17_55675738_55675992 | 1.65 |
RP11-118E18.4 |
|
9908 |
0.2 |
chr6_41904753_41905210 | 1.65 |
CCND3 |
cyclin D3 |
3483 |
0.16 |
chr9_139299169_139299735 | 1.65 |
SDCCAG3 |
serologically defined colon cancer antigen 3 |
2185 |
0.17 |
chr12_4005612_4005828 | 1.65 |
RP11-664D1.1 |
|
2499 |
0.35 |
chr7_36678667_36679209 | 1.65 |
ENSG00000221561 |
. |
2911 |
0.3 |
chr8_82017640_82017890 | 1.64 |
PAG1 |
phosphoprotein associated with glycosphingolipid microdomains 1 |
6538 |
0.31 |
chr15_64720015_64720166 | 1.63 |
TRIP4 |
thyroid hormone receptor interactor 4 |
3776 |
0.14 |
chr3_73014996_73015147 | 1.63 |
GXYLT2 |
glucoside xylosyltransferase 2 |
10705 |
0.2 |
chr18_60884525_60884912 | 1.63 |
ENSG00000238988 |
. |
22820 |
0.2 |
chr14_99689376_99689586 | 1.63 |
AL109767.1 |
|
39804 |
0.16 |
chr11_128652699_128652977 | 1.63 |
FLI1 |
Fli-1 proto-oncogene, ETS transcription factor |
18153 |
0.2 |
chr7_142420697_142420892 | 1.63 |
PRSS1 |
protease, serine, 1 (trypsin 1) |
36525 |
0.15 |
chr5_74353062_74353477 | 1.63 |
GCNT4 |
glucosaminyl (N-acetyl) transferase 4, core 2 |
26545 |
0.23 |
chr3_42599327_42599478 | 1.62 |
SEC22C |
SEC22 vesicle trafficking protein homolog C (S. cerevisiae) |
5722 |
0.15 |
chr14_31679082_31679233 | 1.62 |
HECTD1 |
HECT domain containing E3 ubiquitin protein ligase 1 |
2147 |
0.28 |
chr1_148854279_148854641 | 1.62 |
ENSG00000222854 |
. |
58922 |
0.13 |
chr14_50411900_50412331 | 1.62 |
ENSG00000251929 |
. |
43447 |
0.1 |
chr19_6775270_6775712 | 1.62 |
VAV1 |
vav 1 guanine nucleotide exchange factor |
2522 |
0.19 |
chr20_33129370_33129521 | 1.62 |
MAP1LC3A |
microtubule-associated protein 1 light chain 3 alpha |
5213 |
0.17 |
chr2_198186923_198187179 | 1.61 |
AC010746.3 |
|
10934 |
0.16 |
chr7_142503625_142503977 | 1.61 |
PRSS3P2 |
protease, serine, 3 pseudogene 2 |
22670 |
0.15 |
chr1_151869347_151869629 | 1.61 |
THEM4 |
thioesterase superfamily member 4 |
12625 |
0.12 |
chr1_90097018_90097733 | 1.60 |
RP5-1007M22.2 |
|
375 |
0.77 |
chr2_198769066_198769554 | 1.60 |
PLCL1 |
phospholipase C-like 1 |
94328 |
0.08 |
chr5_156451707_156451858 | 1.60 |
HAVCR1 |
hepatitis A virus cellular receptor 1 |
33625 |
0.15 |
chr3_98274734_98275185 | 1.60 |
GPR15 |
G protein-coupled receptor 15 |
24216 |
0.13 |
chr17_78822051_78822202 | 1.60 |
RP11-28G8.1 |
|
42694 |
0.13 |
chr4_109033032_109033365 | 1.59 |
LEF1 |
lymphoid enhancer-binding factor 1 |
54259 |
0.13 |
chr12_21768112_21768692 | 1.59 |
GYS2 |
glycogen synthase 2 (liver) |
10621 |
0.19 |
chr1_101394971_101395556 | 1.59 |
SLC30A7 |
solute carrier family 30 (zinc transporter), member 7 |
32121 |
0.12 |
chr7_38406396_38406561 | 1.59 |
AMPH |
amphiphysin |
96235 |
0.09 |
chr17_61829448_61829834 | 1.59 |
STRADA |
STE20-related kinase adaptor alpha |
10311 |
0.13 |
chr4_100737406_100737644 | 1.59 |
DAPP1 |
dual adaptor of phosphotyrosine and 3-phosphoinositides |
465 |
0.87 |
chr1_100876837_100877178 | 1.58 |
ENSG00000216067 |
. |
32676 |
0.16 |
chr4_40208821_40209053 | 1.58 |
RHOH |
ras homolog family member H |
6973 |
0.23 |
chr1_121138182_121138423 | 1.58 |
FCGR1B |
Fc fragment of IgG, high affinity Ib, receptor (CD64) |
202365 |
0.03 |
chr1_160430800_160431049 | 1.58 |
ENSG00000223009 |
. |
42322 |
0.1 |
chr2_143981742_143981925 | 1.58 |
RP11-190J23.1 |
|
52092 |
0.17 |
chr13_74601733_74602123 | 1.58 |
KLF12 |
Kruppel-like factor 12 |
32742 |
0.25 |
chr7_98530386_98530549 | 1.57 |
TRRAP |
transformation/transcription domain-associated protein |
32164 |
0.15 |
chr7_158936629_158936995 | 1.57 |
VIPR2 |
vasoactive intestinal peptide receptor 2 |
732 |
0.8 |
chr2_204818847_204819034 | 1.57 |
ICOS |
inducible T-cell co-stimulator |
17437 |
0.27 |
chr3_46334379_46334530 | 1.57 |
CCR3 |
chemokine (C-C motif) receptor 3 |
27835 |
0.17 |
chr12_90154633_90155100 | 1.57 |
ENSG00000252823 |
. |
7030 |
0.23 |
chr2_219348322_219348473 | 1.57 |
ENSG00000222714 |
. |
17363 |
0.13 |
chr5_74973503_74973862 | 1.56 |
ENSG00000207333 |
. |
31742 |
0.16 |
chr8_125598011_125598209 | 1.56 |
RP11-532M24.1 |
|
6238 |
0.19 |
chr11_68295964_68296242 | 1.56 |
PPP6R3 |
protein phosphatase 6, regulatory subunit 3 |
6776 |
0.19 |
chr15_80352609_80352760 | 1.56 |
ZFAND6 |
zinc finger, AN1-type domain 6 |
82 |
0.98 |
chr14_72399560_72399713 | 1.56 |
RGS6 |
regulator of G-protein signaling 6 |
197 |
0.96 |
chr5_56141437_56141733 | 1.56 |
ENSG00000238717 |
. |
11390 |
0.16 |
chr11_6762047_6762301 | 1.56 |
GVINP1 |
GTPase, very large interferon inducible pseudogene 1 |
19063 |
0.11 |
chr11_73702302_73702453 | 1.56 |
UCP2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
8025 |
0.14 |
chr14_61866706_61866938 | 1.56 |
PRKCH |
protein kinase C, eta |
9410 |
0.25 |
chr16_73092870_73093114 | 1.56 |
ZFHX3 |
zinc finger homeobox 3 |
605 |
0.79 |
chr11_3991307_3991580 | 1.55 |
STIM1 |
stromal interaction molecule 1 |
22870 |
0.17 |
chr2_68947906_68948169 | 1.55 |
ARHGAP25 |
Rho GTPase activating protein 25 |
10403 |
0.25 |
chr2_191298128_191298279 | 1.54 |
MFSD6 |
major facilitator superfamily domain containing 6 |
1824 |
0.36 |
chr17_38779166_38779543 | 1.54 |
SMARCE1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 |
9188 |
0.15 |
chr14_22973101_22973316 | 1.54 |
TRAJ51 |
T cell receptor alpha joining 51 (pseudogene) |
17037 |
0.09 |
chr14_61864788_61865077 | 1.54 |
PRKCH |
protein kinase C, eta |
7520 |
0.26 |
chr1_117310316_117310601 | 1.54 |
CD2 |
CD2 molecule |
13369 |
0.21 |
chrX_78213061_78213264 | 1.54 |
P2RY10 |
purinergic receptor P2Y, G-protein coupled, 10 |
12244 |
0.31 |
chr8_8196267_8196894 | 1.54 |
SGK223 |
Tyrosine-protein kinase SgK223 |
42677 |
0.16 |
chr22_42659748_42659899 | 1.53 |
TCF20 |
transcription factor 20 (AR1) |
48375 |
0.13 |
chr9_134546194_134546574 | 1.53 |
RAPGEF1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
38845 |
0.16 |
chr8_95975377_95975528 | 1.53 |
NDUFAF6 |
NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 |
5216 |
0.16 |
chr18_3060720_3060948 | 1.53 |
ENSG00000252353 |
. |
32732 |
0.14 |
chr16_11059004_11059432 | 1.53 |
CLEC16A |
C-type lectin domain family 16, member A |
20780 |
0.13 |
chr12_22317349_22317644 | 1.53 |
ENSG00000212172 |
. |
31067 |
0.22 |
chr3_186756396_186756829 | 1.52 |
ST6GAL1 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
4919 |
0.27 |
chr6_154569291_154569730 | 1.52 |
IPCEF1 |
interaction protein for cytohesin exchange factors 1 |
694 |
0.82 |
chr8_71519355_71519651 | 1.52 |
TRAM1 |
translocation associated membrane protein 1 |
510 |
0.64 |
chr2_129512356_129512644 | 1.52 |
ENSG00000238379 |
. |
309728 |
0.01 |
chr7_151125685_151126226 | 1.52 |
RP4-555L14.4 |
|
1186 |
0.33 |
chr21_43607475_43608056 | 1.52 |
ABCG1 |
ATP-binding cassette, sub-family G (WHITE), member 1 |
12034 |
0.19 |
chr12_94426681_94426856 | 1.51 |
ENSG00000223126 |
. |
23945 |
0.22 |
chr2_204975625_204975880 | 1.51 |
ICOS |
inducible T-cell co-stimulator |
174249 |
0.03 |
chr2_95741879_95742163 | 1.51 |
AC103563.9 |
|
23100 |
0.15 |
chr10_105661794_105662036 | 1.51 |
OBFC1 |
oligonucleotide/oligosaccharide-binding fold containing 1 |
15512 |
0.16 |
chr12_92793841_92794176 | 1.51 |
RP11-693J15.4 |
|
21299 |
0.18 |
chr2_198172189_198172384 | 1.51 |
ANKRD44 |
ankyrin repeat domain 44 |
3225 |
0.2 |
chr16_79312025_79312573 | 1.51 |
ENSG00000222244 |
. |
13948 |
0.29 |
chr10_131968884_131969090 | 1.51 |
GLRX3 |
glutaredoxin 3 |
34324 |
0.24 |
chr4_78777171_78777342 | 1.51 |
MRPL1 |
mitochondrial ribosomal protein L1 |
6418 |
0.27 |
chr10_9051598_9051896 | 1.50 |
ENSG00000212505 |
. |
352953 |
0.01 |
chr15_75137179_75137423 | 1.50 |
ULK3 |
unc-51 like kinase 3 |
1763 |
0.22 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 12.9 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
3.1 | 3.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
3.0 | 9.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
2.5 | 9.8 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
2.4 | 9.7 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
2.3 | 7.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
2.1 | 6.4 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
2.0 | 8.2 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.8 | 5.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.8 | 14.6 | GO:0007172 | signal complex assembly(GO:0007172) |
1.7 | 5.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.6 | 4.9 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
1.6 | 3.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.6 | 4.8 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.6 | 6.4 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.5 | 4.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.5 | 1.5 | GO:0002666 | tolerance induction to self antigen(GO:0002513) T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
1.5 | 11.8 | GO:0006491 | N-glycan processing(GO:0006491) |
1.5 | 5.9 | GO:0002335 | mature B cell differentiation(GO:0002335) |
1.5 | 10.2 | GO:0002839 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
1.4 | 4.3 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
1.4 | 7.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.4 | 4.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.4 | 2.7 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
1.4 | 2.7 | GO:0006154 | adenosine catabolic process(GO:0006154) |
1.4 | 13.5 | GO:0043368 | positive T cell selection(GO:0043368) |
1.3 | 1.3 | GO:0046827 | regulation of protein export from nucleus(GO:0046825) positive regulation of protein export from nucleus(GO:0046827) |
1.3 | 2.5 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
1.2 | 4.9 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
1.2 | 4.8 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
1.2 | 3.6 | GO:0015917 | aminophospholipid transport(GO:0015917) |
1.2 | 3.6 | GO:0070602 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
1.1 | 3.4 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
1.1 | 5.6 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
1.1 | 3.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.1 | 3.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.1 | 3.2 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
1.1 | 3.2 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
1.1 | 5.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
1.1 | 3.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.1 | 5.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
1.0 | 72.3 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
1.0 | 4.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
1.0 | 8.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.0 | 4.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.0 | 3.9 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
1.0 | 3.8 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.0 | 2.9 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
1.0 | 1.9 | GO:0001821 | histamine secretion(GO:0001821) |
0.9 | 2.8 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.9 | 3.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.9 | 4.6 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.9 | 3.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.9 | 1.8 | GO:0002710 | negative regulation of lymphocyte mediated immunity(GO:0002707) negative regulation of T cell mediated immunity(GO:0002710) |
0.9 | 1.8 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.9 | 4.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.9 | 8.7 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.9 | 0.9 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.9 | 2.6 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.8 | 1.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.8 | 0.8 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.8 | 2.5 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.8 | 1.6 | GO:0010761 | fibroblast migration(GO:0010761) |
0.8 | 2.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.8 | 2.4 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.8 | 5.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.8 | 2.3 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.8 | 2.3 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.8 | 3.9 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.8 | 4.5 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.8 | 2.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.7 | 1.5 | GO:0034393 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.7 | 0.7 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.7 | 2.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.7 | 0.7 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.7 | 2.2 | GO:0060596 | mammary placode formation(GO:0060596) |
0.7 | 1.5 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.7 | 10.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.7 | 1.4 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.7 | 2.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.7 | 7.8 | GO:0031648 | protein destabilization(GO:0031648) |
0.7 | 1.4 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.7 | 1.4 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.7 | 2.1 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.7 | 10.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.7 | 0.7 | GO:0001743 | optic placode formation(GO:0001743) |
0.7 | 1.4 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.7 | 2.7 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.7 | 1.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.7 | 2.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.7 | 7.8 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.7 | 2.6 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.6 | 1.3 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.6 | 1.9 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.6 | 0.6 | GO:0048539 | bone marrow development(GO:0048539) |
0.6 | 1.9 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.6 | 1.9 | GO:0002507 | tolerance induction(GO:0002507) |
0.6 | 1.9 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.6 | 0.6 | GO:0043393 | regulation of protein binding(GO:0043393) |
0.6 | 6.9 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.6 | 1.9 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.6 | 4.3 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.6 | 3.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.6 | 1.2 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.6 | 3.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.6 | 1.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.6 | 3.0 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.6 | 0.6 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.6 | 4.2 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.6 | 3.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.6 | 0.6 | GO:0006828 | manganese ion transport(GO:0006828) |
0.6 | 1.2 | GO:0033622 | integrin activation(GO:0033622) |
0.6 | 0.6 | GO:0032661 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.6 | 0.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.6 | 0.6 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.6 | 1.8 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.6 | 0.6 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.6 | 15.8 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.6 | 1.7 | GO:0001914 | regulation of T cell mediated cytotoxicity(GO:0001914) |
0.6 | 4.6 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.6 | 0.6 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.6 | 0.6 | GO:0033079 | immature T cell proliferation(GO:0033079) immature T cell proliferation in thymus(GO:0033080) |
0.6 | 1.1 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.6 | 0.6 | GO:0001866 | natural killer cell proliferation(GO:0001787) NK T cell proliferation(GO:0001866) NK T cell activation(GO:0051132) |
0.6 | 1.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.6 | 2.8 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.6 | 7.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.6 | 0.6 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.6 | 2.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.6 | 0.6 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.6 | 2.3 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.6 | 1.7 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.6 | 10.1 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.6 | 1.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.6 | 1.7 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.6 | 0.6 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) sodium ion export(GO:0071436) |
0.6 | 3.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.6 | 1.7 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.6 | 1.1 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.6 | 2.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.5 | 1.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.5 | 0.5 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.5 | 2.2 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.5 | 1.1 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.5 | 1.6 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.5 | 2.7 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.5 | 0.5 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.5 | 3.2 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.5 | 1.1 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.5 | 0.5 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.5 | 2.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.5 | 1.6 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.5 | 0.5 | GO:0001832 | blastocyst growth(GO:0001832) |
0.5 | 2.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.5 | 1.6 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.5 | 6.8 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.5 | 0.5 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.5 | 0.5 | GO:0021612 | cranial nerve structural organization(GO:0021604) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) |
0.5 | 2.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.5 | 2.6 | GO:0060023 | soft palate development(GO:0060023) |
0.5 | 0.5 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.5 | 2.6 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.5 | 2.6 | GO:0021684 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.5 | 1.0 | GO:0072162 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.5 | 1.0 | GO:1901978 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.5 | 1.5 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.5 | 1.5 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.5 | 0.5 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.5 | 6.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.5 | 2.5 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.5 | 1.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.5 | 8.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.5 | 1.0 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.5 | 1.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.5 | 2.0 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.5 | 0.5 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.5 | 2.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.5 | 2.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.5 | 1.0 | GO:0072074 | kidney mesenchyme development(GO:0072074) metanephric mesenchyme development(GO:0072075) kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.5 | 11.6 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.5 | 1.9 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.5 | 1.0 | GO:0009405 | pathogenesis(GO:0009405) |
0.5 | 2.9 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.5 | 2.4 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.5 | 1.0 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.5 | 7.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 3.3 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.5 | 0.5 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.5 | 5.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.5 | 1.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.5 | 2.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.5 | 1.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.5 | 1.9 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.5 | 4.6 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.5 | 1.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.5 | 1.8 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.5 | 0.5 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.5 | 1.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 3.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.5 | 0.9 | GO:0034776 | response to histamine(GO:0034776) |
0.4 | 1.8 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.4 | 1.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 2.2 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.4 | 0.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.4 | 0.9 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.4 | 1.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.4 | 2.2 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.4 | 0.4 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.4 | 0.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.4 | 3.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.4 | 4.0 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.4 | 1.3 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.4 | 0.4 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.4 | 0.9 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.4 | 0.9 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.4 | 1.3 | GO:0046666 | retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
0.4 | 0.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.4 | 1.3 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.4 | 2.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.4 | 0.4 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.4 | 1.3 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.4 | 0.9 | GO:0017085 | response to insecticide(GO:0017085) |
0.4 | 1.3 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.4 | 0.8 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.4 | 1.7 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.4 | 1.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.4 | 2.5 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.4 | 1.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.4 | 0.8 | GO:0010536 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.4 | 1.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.4 | 0.4 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.4 | 0.8 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.4 | 3.3 | GO:0006983 | ER overload response(GO:0006983) |
0.4 | 1.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.4 | 1.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.4 | 1.6 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 0.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.4 | 2.4 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.4 | 2.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.4 | 1.6 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.4 | 0.4 | GO:0048478 | replication fork protection(GO:0048478) |
0.4 | 1.6 | GO:1902583 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.4 | 0.4 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.4 | 0.4 | GO:0031223 | auditory behavior(GO:0031223) |
0.4 | 0.8 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.4 | 0.8 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.4 | 1.6 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.4 | 10.7 | GO:0006903 | vesicle targeting(GO:0006903) |
0.4 | 2.0 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.4 | 0.4 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.4 | 6.3 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.4 | 4.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.4 | 3.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.4 | 0.8 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.4 | 1.2 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.4 | 1.2 | GO:0032506 | cytokinetic process(GO:0032506) |
0.4 | 1.2 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.4 | 1.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.4 | 1.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.4 | 1.2 | GO:0032364 | oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
0.4 | 0.4 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.4 | 3.5 | GO:0032456 | endocytic recycling(GO:0032456) |
0.4 | 3.1 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.4 | 1.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.4 | 2.7 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.4 | 0.4 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
0.4 | 2.7 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.4 | 1.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 0.4 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.4 | 0.4 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.4 | 1.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.4 | 1.1 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.4 | 2.7 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.4 | 1.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.4 | 2.6 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.4 | 1.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.4 | 0.8 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.4 | 0.8 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.4 | 10.5 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.4 | 3.0 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.4 | 0.4 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.4 | 0.7 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.4 | 1.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.4 | 0.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.4 | 1.5 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.4 | 0.7 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.4 | 1.5 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.4 | 0.4 | GO:0018343 | protein farnesylation(GO:0018343) |
0.4 | 1.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.4 | 0.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 1.8 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.4 | 0.7 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.4 | 2.2 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.4 | 3.3 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.4 | 6.6 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.4 | 1.1 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.4 | 1.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.4 | 0.7 | GO:0072224 | metanephric glomerulus development(GO:0072224) metanephric glomerulus vasculature development(GO:0072239) |
0.4 | 2.2 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.4 | 1.8 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.4 | 0.4 | GO:0002076 | osteoblast development(GO:0002076) |
0.4 | 0.7 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.4 | 1.4 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.4 | 1.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.4 | 25.0 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.4 | 0.4 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.4 | 1.4 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.4 | 0.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.4 | 6.7 | GO:0006997 | nucleus organization(GO:0006997) |
0.4 | 0.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 1.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.4 | 0.4 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.4 | 1.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.4 | 1.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.3 | 1.0 | GO:0045056 | transcytosis(GO:0045056) |
0.3 | 1.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 0.7 | GO:0008049 | male courtship behavior(GO:0008049) |
0.3 | 0.3 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.3 | 0.3 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.3 | 0.3 | GO:0060433 | bronchus development(GO:0060433) |
0.3 | 1.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 2.8 | GO:0001662 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
0.3 | 0.7 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.3 | 0.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 1.0 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.3 | 1.4 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.3 | 1.4 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.3 | 2.1 | GO:0030449 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.3 | 0.7 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.3 | 0.7 | GO:0032109 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.3 | 0.7 | GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002460) |
0.3 | 0.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.3 | 1.7 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.3 | 0.3 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.3 | 0.7 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.3 | 0.3 | GO:0022038 | corpus callosum development(GO:0022038) |
0.3 | 6.2 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.3 | 0.7 | GO:0031034 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 0.7 | GO:0034143 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
0.3 | 0.7 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.3 | 0.3 | GO:0051154 | negative regulation of myotube differentiation(GO:0010832) negative regulation of striated muscle cell differentiation(GO:0051154) |
0.3 | 0.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 1.3 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.3 | 1.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 3.6 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 2.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 0.3 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.3 | 1.0 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.3 | 0.3 | GO:0010506 | regulation of autophagy(GO:0010506) |
0.3 | 1.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 0.3 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.3 | 7.1 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.3 | 0.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.3 | 6.7 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.3 | 1.3 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.3 | 1.6 | GO:0098930 | axonal transport(GO:0098930) |
0.3 | 2.9 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.3 | 1.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 0.6 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.3 | 1.0 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.3 | 1.9 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.3 | 0.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 0.9 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 4.4 | GO:0007032 | endosome organization(GO:0007032) |
0.3 | 2.8 | GO:0000303 | response to superoxide(GO:0000303) |
0.3 | 1.3 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.3 | 1.9 | GO:0016556 | mRNA modification(GO:0016556) |
0.3 | 0.6 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.3 | 1.2 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 0.9 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.3 | 0.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 1.2 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.3 | 2.8 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.3 | 1.2 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.3 | 6.4 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.3 | 0.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 0.9 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.3 | 6.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 0.6 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.3 | 1.8 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.3 | 1.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.3 | 0.6 | GO:0032925 | regulation of activin receptor signaling pathway(GO:0032925) |
0.3 | 0.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 0.9 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.3 | 0.3 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.3 | 3.0 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.3 | 0.6 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.3 | 0.3 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.3 | 1.2 | GO:0009799 | specification of symmetry(GO:0009799) |
0.3 | 1.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.3 | 0.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 1.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.3 | 0.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 15.0 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.3 | 1.2 | GO:0048535 | lymph node development(GO:0048535) |
0.3 | 13.8 | GO:0007498 | mesoderm development(GO:0007498) |
0.3 | 0.3 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.3 | 0.6 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.3 | 0.3 | GO:0021575 | hindbrain morphogenesis(GO:0021575) |
0.3 | 3.8 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.3 | 6.4 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.3 | 1.7 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.3 | 2.0 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.3 | 0.3 | GO:0061339 | establishment of apical/basal cell polarity(GO:0035089) establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.3 | 3.2 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.3 | 0.9 | GO:0070265 | necrotic cell death(GO:0070265) |
0.3 | 0.9 | GO:0051182 | coenzyme transport(GO:0051182) |
0.3 | 0.3 | GO:0051445 | regulation of meiotic nuclear division(GO:0040020) regulation of meiotic cell cycle(GO:0051445) |
0.3 | 2.9 | GO:0045730 | respiratory burst(GO:0045730) |
0.3 | 2.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 2.6 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.3 | 2.0 | GO:0016925 | protein sumoylation(GO:0016925) |
0.3 | 0.9 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.3 | 0.3 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.3 | 1.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.3 | 1.4 | GO:0001906 | cell killing(GO:0001906) |
0.3 | 3.1 | GO:0001510 | RNA methylation(GO:0001510) |
0.3 | 1.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.3 | 0.6 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.3 | 1.7 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.3 | 0.8 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.3 | 2.5 | GO:1901071 | N-acetylglucosamine metabolic process(GO:0006044) glucosamine-containing compound metabolic process(GO:1901071) |
0.3 | 3.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.3 | 2.5 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 2.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.3 | 0.3 | GO:0000154 | rRNA modification(GO:0000154) |
0.3 | 3.6 | GO:0009303 | rRNA transcription(GO:0009303) |
0.3 | 0.3 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.3 | 0.6 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.3 | 0.6 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.3 | 0.6 | GO:0060008 | Sertoli cell differentiation(GO:0060008) Sertoli cell development(GO:0060009) |
0.3 | 6.9 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.3 | 0.6 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.3 | 0.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.3 | 12.6 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.3 | 3.6 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.3 | 3.8 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.3 | 2.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 0.3 | GO:0060021 | palate development(GO:0060021) |
0.3 | 0.3 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.3 | 1.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 1.1 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.3 | 0.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.3 | 1.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.3 | 0.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.3 | 3.0 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 1.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.3 | 1.6 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.3 | 3.8 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.3 | 2.7 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.3 | 1.3 | GO:0007530 | sex determination(GO:0007530) |
0.3 | 0.8 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.3 | 0.8 | GO:0051169 | nuclear transport(GO:0051169) |
0.3 | 0.5 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.3 | 2.9 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.3 | 1.8 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.3 | 0.5 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.3 | 0.8 | GO:0071569 | protein ufmylation(GO:0071569) |
0.3 | 0.5 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.3 | 11.5 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.3 | 0.5 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.3 | 7.0 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.3 | 1.0 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.3 | 1.6 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.3 | 0.8 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 1.3 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.3 | 2.6 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.3 | 0.5 | GO:0032924 | activin receptor signaling pathway(GO:0032924) |
0.3 | 14.1 | GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.3 | 0.3 | GO:0043574 | peroxisomal transport(GO:0043574) |
0.3 | 1.0 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.3 | 0.5 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.3 | 2.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.3 | 8.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.3 | 0.3 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.3 | 0.3 | GO:0051322 | anaphase(GO:0051322) |
0.3 | 0.8 | GO:0042921 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
0.3 | 1.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 0.5 | GO:0003094 | regulation of glomerular filtration(GO:0003093) glomerular filtration(GO:0003094) renal filtration(GO:0097205) regulation of renal system process(GO:0098801) |
0.3 | 1.5 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.3 | 0.8 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 0.3 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 0.3 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.3 | 2.0 | GO:0060678 | dichotomous subdivision of terminal units involved in ureteric bud branching(GO:0060678) |
0.3 | 0.3 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.3 | 0.3 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.3 | 0.5 | GO:0090179 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.2 | 5.7 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 0.2 | GO:0007041 | lysosomal transport(GO:0007041) |
0.2 | 1.2 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.2 | 0.2 | GO:0071503 | response to heparin(GO:0071503) |
0.2 | 9.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 1.2 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.2 | 0.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 1.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.2 | 1.0 | GO:0001706 | endoderm formation(GO:0001706) |
0.2 | 0.5 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.2 | 0.7 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 0.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 2.4 | GO:0006862 | nucleotide transport(GO:0006862) |
0.2 | 1.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 0.2 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.2 | 0.2 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.2 | 0.7 | GO:0061647 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.2 | 53.9 | GO:0006397 | mRNA processing(GO:0006397) |
0.2 | 4.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 0.5 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.2 | GO:0003211 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.2 | 1.9 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.2 | 0.7 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.2 | 0.7 | GO:0043487 | regulation of RNA stability(GO:0043487) |
0.2 | 2.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 0.5 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.2 | 0.7 | GO:1902808 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.2 | 0.5 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.2 | 0.2 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.2 | 0.5 | GO:0032329 | serine transport(GO:0032329) |
0.2 | 0.5 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.2 | 3.3 | GO:0006959 | humoral immune response(GO:0006959) |
0.2 | 2.6 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.2 | 0.5 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.2 | 2.8 | GO:0000097 | sulfur amino acid biosynthetic process(GO:0000097) |
0.2 | 1.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.2 | 0.7 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.2 | 0.2 | GO:0042311 | vasodilation(GO:0042311) |
0.2 | 3.1 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 0.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.2 | 0.5 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.2 | 0.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.2 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.2 | 0.7 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.2 | 0.9 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 0.2 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.2 | 5.3 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.2 | 0.7 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 0.2 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.2 | 3.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.2 | 1.8 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.2 | 0.7 | GO:0006325 | chromatin organization(GO:0006325) |
0.2 | 0.2 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.2 | 0.7 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.2 | 2.1 | GO:0051251 | positive regulation of lymphocyte activation(GO:0051251) |
0.2 | 0.2 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.2 | 0.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 0.5 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 1.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.7 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 0.2 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 5.9 | GO:0072655 | establishment of protein localization to mitochondrion(GO:0072655) |
0.2 | 0.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 2.0 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 0.2 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.2 | 0.7 | GO:0060992 | response to fungicide(GO:0060992) |
0.2 | 0.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.7 | GO:0034644 | cellular response to UV(GO:0034644) |
0.2 | 0.9 | GO:1902400 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.2 | 0.4 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 0.7 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.2 | 2.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 1.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 3.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.2 | 0.9 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.2 | 3.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.4 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.2 | 0.4 | GO:0072202 | cell differentiation involved in metanephros development(GO:0072202) |
0.2 | 0.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.7 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.2 | 1.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.7 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 0.9 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 0.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.4 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.2 | 0.2 | GO:0034112 | positive regulation of homotypic cell-cell adhesion(GO:0034112) |
0.2 | 0.6 | GO:0032402 | melanosome transport(GO:0032402) |
0.2 | 0.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 2.1 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.2 | 0.6 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 0.8 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.2 | 1.9 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.2 | 0.6 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.2 | 0.4 | GO:1901215 | negative regulation of neuron apoptotic process(GO:0043524) negative regulation of neuron death(GO:1901215) |
0.2 | 0.2 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.2 | 0.6 | GO:0035082 | axoneme assembly(GO:0035082) |
0.2 | 0.8 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.2 | 1.3 | GO:0046036 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.2 | 2.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.2 | 0.2 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.2 | 0.4 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.2 | 0.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 0.6 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.2 | 0.2 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 0.2 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.2 | 6.3 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 0.2 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.2 | 14.3 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.2 | 2.2 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.2 | 1.0 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.2 | 0.4 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 1.2 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.2 | 0.4 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 0.2 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.2 | 0.4 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 3.2 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.2 | 0.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 0.8 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
0.2 | 0.6 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 0.2 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.2 | 0.8 | GO:0002097 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.2 | 0.4 | GO:0046386 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) deoxyribose phosphate catabolic process(GO:0046386) |
0.2 | 2.2 | GO:0015669 | gas transport(GO:0015669) |
0.2 | 0.4 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 1.0 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.2 | 0.8 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.2 | 2.0 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.2 | 1.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.8 | GO:0050718 | positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.2 | 0.4 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.2 | 5.0 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.2 | 5.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 1.4 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.2 | 1.0 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.4 | GO:0019730 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.2 | 1.0 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 1.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.9 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.2 | 4.5 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.2 | 4.0 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.2 | 0.8 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.2 | 0.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 0.4 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.2 | 4.5 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.2 | 0.2 | GO:0050951 | detection of temperature stimulus(GO:0016048) sensory perception of temperature stimulus(GO:0050951) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.4 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 0.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.4 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.2 | 0.5 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 0.7 | GO:0007140 | male meiosis(GO:0007140) |
0.2 | 1.1 | GO:1902749 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.2 | 2.9 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 0.2 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.2 | 0.4 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.5 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 22.8 | GO:0016568 | chromatin modification(GO:0016568) |
0.2 | 0.2 | GO:0045058 | T cell selection(GO:0045058) |
0.2 | 1.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.2 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.2 | 1.8 | GO:1903305 | regulation of regulated secretory pathway(GO:1903305) |
0.2 | 0.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 52.9 | GO:0006412 | translation(GO:0006412) |
0.2 | 3.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.2 | 0.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.2 | 0.7 | GO:0051208 | sequestering of calcium ion(GO:0051208) |
0.2 | 1.1 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.2 | 0.2 | GO:0051325 | interphase(GO:0051325) |
0.2 | 0.5 | GO:0045851 | pH reduction(GO:0045851) |
0.2 | 0.2 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
0.2 | 0.2 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.2 | 0.2 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.2 | 6.5 | GO:0015992 | proton transport(GO:0015992) |
0.2 | 1.9 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.2 | 0.4 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 0.4 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.2 | 0.7 | GO:0035108 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
0.2 | 1.0 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.2 | 1.0 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.2 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 1.6 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.2 | 0.3 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 0.5 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 0.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.2 | 0.7 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
0.2 | 0.7 | GO:0045843 | negative regulation of striated muscle tissue development(GO:0045843) negative regulation of muscle tissue development(GO:1901862) |
0.2 | 0.5 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.2 | 0.3 | GO:0006323 | DNA packaging(GO:0006323) |
0.2 | 2.4 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.2 | 3.9 | GO:0044782 | cilium organization(GO:0044782) |
0.2 | 0.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.5 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.2 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 0.7 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 1.2 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.2 | 0.8 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 0.3 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.2 | 1.0 | GO:0042891 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.2 | 0.8 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.2 | 1.0 | GO:0009409 | response to cold(GO:0009409) |
0.2 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 1.3 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.2 | 0.2 | GO:1903306 | negative regulation of regulated secretory pathway(GO:1903306) |
0.2 | 0.2 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 1.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 0.3 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.2 | 0.2 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.5 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.2 | 0.5 | GO:0046849 | bone remodeling(GO:0046849) |
0.2 | 3.8 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.2 | 0.3 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.2 | 0.3 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.2 | 1.1 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.2 | 0.3 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 2.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 0.8 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 0.9 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 1.5 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.2 | 0.3 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.2 | 0.2 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 1.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 4.3 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.2 | 0.9 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.2 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 0.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.2 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 0.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.2 | 0.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.9 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 0.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.2 | 0.8 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.9 | GO:0045165 | cell fate commitment(GO:0045165) |
0.1 | 0.4 | GO:1903556 | negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.1 | 0.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 2.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.6 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.9 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.1 | 15.1 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.3 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.3 | GO:0048017 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.1 | 0.1 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.1 | 5.2 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 1.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.3 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.1 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.3 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.1 | 0.3 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
0.1 | 1.3 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.1 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.6 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.7 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.1 | 0.1 | GO:0021675 | nerve development(GO:0021675) |
0.1 | 10.9 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.6 | GO:0010669 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 1.0 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.1 | 0.3 | GO:0044819 | mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) mitotic G1/S transition checkpoint(GO:0044819) |
0.1 | 0.4 | GO:1901889 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.1 | 0.4 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.6 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.4 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 4.2 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.1 | 1.4 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.1 | 1.5 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.3 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.7 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.8 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.5 | GO:0003143 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) determination of heart left/right asymmetry(GO:0061371) |
0.1 | 0.3 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.9 | GO:0045446 | endothelium development(GO:0003158) endothelial cell differentiation(GO:0045446) |
0.1 | 0.3 | GO:0061008 | hepaticobiliary system development(GO:0061008) |
0.1 | 0.9 | GO:0048864 | stem cell development(GO:0048864) |
0.1 | 0.1 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
0.1 | 1.1 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
0.1 | 0.3 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.1 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.9 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.3 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.1 | GO:1903008 | organelle disassembly(GO:1903008) |
0.1 | 0.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.4 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 0.9 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 1.0 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.6 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.1 | 0.1 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 12.6 | GO:0050776 | regulation of immune response(GO:0050776) |
0.1 | 0.4 | GO:0050670 | regulation of lymphocyte proliferation(GO:0050670) |
0.1 | 0.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.3 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.1 | 0.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.3 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 1.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 1.4 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.9 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.1 | 0.3 | GO:0051924 | regulation of calcium ion transport(GO:0051924) |
0.1 | 0.4 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.1 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.1 | 0.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.1 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.1 | 0.1 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.5 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
0.1 | 0.1 | GO:1903729 | regulation of plasma membrane organization(GO:1903729) |
0.1 | 0.1 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.7 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.1 | 0.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.1 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.1 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.1 | GO:0045321 | leukocyte activation(GO:0045321) |
0.1 | 0.4 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.2 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.1 | GO:0021754 | facial nucleus development(GO:0021754) |
0.1 | 0.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 5.3 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.4 | GO:0051298 | centrosome duplication(GO:0051298) |
0.1 | 2.0 | GO:0009615 | response to virus(GO:0009615) |
0.1 | 0.1 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.1 | 0.7 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.4 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.1 | 1.2 | GO:0034762 | regulation of transmembrane transport(GO:0034762) |
0.1 | 0.1 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 1.0 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.6 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.1 | GO:0016198 | axon choice point recognition(GO:0016198) axon midline choice point recognition(GO:0016199) |
0.1 | 4.7 | GO:0070647 | protein modification by small protein conjugation or removal(GO:0070647) |
0.1 | 0.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 1.3 | GO:0016236 | macroautophagy(GO:0016236) |
0.1 | 0.9 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.1 | 0.2 | GO:0060411 | cardiac septum morphogenesis(GO:0060411) |
0.1 | 0.7 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 1.0 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.2 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.1 | 1.6 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.7 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 0.2 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.1 | 0.7 | GO:0042110 | T cell activation(GO:0042110) leukocyte aggregation(GO:0070486) T cell aggregation(GO:0070489) lymphocyte aggregation(GO:0071593) |
0.1 | 1.8 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.1 | 1.1 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.1 | 0.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.4 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
0.1 | 15.7 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 1.2 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.1 | 0.1 | GO:0006312 | mitotic recombination(GO:0006312) |
0.1 | 0.4 | GO:0000718 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.1 | 1.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.7 | GO:0051789 | obsolete response to protein(GO:0051789) |
0.1 | 0.3 | GO:0016444 | somatic diversification of immune receptors via germline recombination within a single locus(GO:0002562) somatic cell DNA recombination(GO:0016444) |
0.1 | 0.2 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.1 | 1.8 | GO:0007204 | positive regulation of cytosolic calcium ion concentration(GO:0007204) |
0.1 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.1 | GO:0046323 | glucose import(GO:0046323) |
0.1 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.5 | GO:0043414 | macromolecule methylation(GO:0043414) |
0.1 | 1.6 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.1 | 1.4 | GO:0006887 | exocytosis(GO:0006887) |
0.1 | 0.6 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.2 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.1 | 0.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.2 | GO:0006560 | proline metabolic process(GO:0006560) |
0.1 | 0.3 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.1 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.3 | GO:0042098 | T cell proliferation(GO:0042098) |
0.1 | 1.2 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 0.5 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.4 | GO:0046649 | lymphocyte activation(GO:0046649) |
0.1 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.3 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.3 | GO:0045007 | depurination(GO:0045007) |
0.1 | 15.4 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.1 | 0.9 | GO:0030278 | regulation of ossification(GO:0030278) |
0.1 | 0.3 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.1 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.7 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 0.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.9 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 2.8 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.6 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.2 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.1 | 0.3 | GO:0048747 | muscle fiber development(GO:0048747) |
0.1 | 0.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.2 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.1 | 0.3 | GO:0061053 | somitogenesis(GO:0001756) somite development(GO:0061053) |
0.1 | 0.2 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.1 | 0.3 | GO:0032970 | regulation of actin filament-based process(GO:0032970) |
0.1 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.5 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.1 | 0.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.2 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.6 | GO:0017157 | regulation of exocytosis(GO:0017157) |
0.1 | 1.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 3.4 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.1 | 0.4 | GO:0051591 | response to cAMP(GO:0051591) |
0.1 | 0.4 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.1 | GO:0019935 | cyclic-nucleotide-mediated signaling(GO:0019935) |
0.1 | 0.1 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.1 | 0.7 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.1 | 4.9 | GO:0006869 | lipid transport(GO:0006869) |
0.1 | 0.1 | GO:0009581 | detection of external stimulus(GO:0009581) |
0.1 | 0.1 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.1 | 0.4 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.1 | 0.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.3 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.7 | GO:0030097 | hemopoiesis(GO:0030097) |
0.1 | 2.2 | GO:0006310 | DNA recombination(GO:0006310) |
0.1 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.4 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.1 | 2.3 | GO:0006909 | phagocytosis(GO:0006909) |
0.1 | 0.4 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.2 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.3 | GO:0006385 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.1 | 0.3 | GO:0010458 | exit from mitosis(GO:0010458) |
0.1 | 0.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.2 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.1 | 0.5 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.2 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.1 | 0.8 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 0.6 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.1 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.1 | GO:1903580 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.1 | 0.2 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.1 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 1.6 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.3 | GO:0006833 | water transport(GO:0006833) |
0.1 | 0.2 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.4 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.5 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.1 | 0.4 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.1 | 0.7 | GO:0000910 | cytokinesis(GO:0000910) |
0.1 | 0.1 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.1 | 0.7 | GO:0051899 | membrane depolarization(GO:0051899) |
0.1 | 0.2 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.4 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.1 | 0.5 | GO:0051147 | regulation of muscle cell differentiation(GO:0051147) |
0.1 | 0.6 | GO:0048678 | response to axon injury(GO:0048678) |
0.1 | 0.2 | GO:0030147 | obsolete natriuresis(GO:0030147) |
0.1 | 0.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 1.2 | GO:0051017 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
0.1 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.6 | GO:0009791 | post-embryonic development(GO:0009791) |
0.1 | 1.3 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.1 | 1.3 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 0.2 | GO:0010771 | negative regulation of cell morphogenesis involved in differentiation(GO:0010771) |
0.1 | 0.4 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
0.1 | 0.6 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 0.1 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body catabolic process(GO:0046952) |
0.1 | 0.2 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.1 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.1 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.8 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 6.1 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.1 | 0.1 | GO:0009437 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.1 | 1.4 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.2 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 0.1 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.1 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.8 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.1 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.1 | 0.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.4 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.1 | 0.9 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) activation of cysteine-type endopeptidase activity(GO:0097202) |
0.1 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.6 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 14.0 | GO:0007599 | hemostasis(GO:0007599) |
0.1 | 0.1 | GO:0007045 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.1 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 1.0 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 0.1 | GO:0031644 | regulation of neurological system process(GO:0031644) |
0.1 | 0.1 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) |
0.1 | 0.2 | GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003337) metanephric renal vesicle morphogenesis(GO:0072283) |
0.1 | 0.1 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.1 | 2.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 0.2 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.7 | GO:0055067 | monovalent inorganic cation homeostasis(GO:0055067) |
0.1 | 0.7 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.1 | 0.1 | GO:0048665 | neuron fate specification(GO:0048665) |
0.1 | 3.5 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.1 | 0.5 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.1 | 0.9 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.1 | 0.1 | GO:0050918 | positive chemotaxis(GO:0050918) |
0.1 | 0.1 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.1 | 0.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.1 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.1 | 0.7 | GO:0009416 | response to light stimulus(GO:0009416) |
0.1 | 0.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.2 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 0.3 | GO:0021515 | cell differentiation in spinal cord(GO:0021515) |
0.1 | 0.1 | GO:0010332 | response to gamma radiation(GO:0010332) |
0.1 | 0.2 | GO:0008216 | spermidine metabolic process(GO:0008216) spermidine biosynthetic process(GO:0008295) |
0.1 | 0.1 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.1 | 0.2 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.1 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.1 | 0.1 | GO:0051098 | regulation of binding(GO:0051098) |
0.1 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 1.2 | GO:0046660 | female sex differentiation(GO:0046660) |
0.1 | 0.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.1 | 5.7 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.1 | 0.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.7 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.2 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.1 | 0.1 | GO:0021533 | cell differentiation in hindbrain(GO:0021533) |
0.1 | 1.3 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.1 | 0.2 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.1 | 0.1 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.1 | 1.4 | GO:0009199 | ribonucleoside triphosphate metabolic process(GO:0009199) purine ribonucleoside triphosphate metabolic process(GO:0009205) |
0.1 | 0.2 | GO:0043523 | regulation of neuron apoptotic process(GO:0043523) regulation of neuron death(GO:1901214) |
0.1 | 2.3 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 1.6 | GO:0032880 | regulation of protein localization(GO:0032880) |
0.1 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.1 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.1 | 0.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.1 | GO:0032891 | negative regulation of organic acid transport(GO:0032891) negative regulation of amino acid transport(GO:0051956) |
0.1 | 0.1 | GO:0044070 | regulation of anion transport(GO:0044070) |
0.1 | 0.6 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 2.7 | GO:0007586 | digestion(GO:0007586) |
0.1 | 0.3 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
0.1 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 12.8 | GO:0012501 | programmed cell death(GO:0012501) |
0.1 | 0.3 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.1 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.1 | GO:0061383 | trabecula formation(GO:0060343) trabecula morphogenesis(GO:0061383) |
0.1 | 0.1 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.1 | 2.3 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.1 | 0.5 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.1 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.6 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.1 | 0.3 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.1 | 0.1 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.1 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.0 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.1 | GO:0007369 | gastrulation(GO:0007369) |
0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0042594 | response to starvation(GO:0042594) |
0.0 | 0.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.0 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.0 | 45.7 | GO:0032774 | RNA biosynthetic process(GO:0032774) |
0.0 | 0.3 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.3 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 10.9 | GO:0015031 | protein transport(GO:0015031) |
0.0 | 0.0 | GO:0030010 | establishment of cell polarity(GO:0030010) |
0.0 | 0.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.2 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.0 | 0.1 | GO:0019827 | stem cell population maintenance(GO:0019827) maintenance of cell number(GO:0098727) |
0.0 | 0.8 | GO:0032940 | secretion by cell(GO:0032940) |
0.0 | 0.6 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.0 | 0.0 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.0 | 0.0 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.0 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.0 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.0 | 1.0 | GO:0008219 | cell death(GO:0008219) |
0.0 | 0.1 | GO:0055006 | cardiac cell development(GO:0055006) cardiac muscle cell development(GO:0055013) |
0.0 | 0.3 | GO:0009266 | response to temperature stimulus(GO:0009266) |
0.0 | 0.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.0 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.1 | GO:0043269 | regulation of ion transport(GO:0043269) |
0.0 | 0.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.1 | GO:0018210 | peptidyl-threonine modification(GO:0018210) |
0.0 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 10.6 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.2 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.0 | GO:0060485 | mesenchyme development(GO:0060485) |
0.0 | 0.1 | GO:0042158 | lipoprotein biosynthetic process(GO:0042158) |
0.0 | 0.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.0 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.0 | 0.4 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 1.4 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.6 | GO:0007015 | actin filament organization(GO:0007015) |
0.0 | 0.0 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.0 | 4.6 | GO:0016310 | phosphorylation(GO:0016310) |
0.0 | 0.0 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.0 | 0.0 | GO:0031427 | response to methotrexate(GO:0031427) |
0.0 | 0.1 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.0 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.0 | 0.0 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.2 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.4 | GO:0016055 | Wnt signaling pathway(GO:0016055) cell-cell signaling by wnt(GO:0198738) |
0.0 | 0.0 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0009755 | hormone-mediated signaling pathway(GO:0009755) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.6 | 13.1 | GO:0001891 | phagocytic cup(GO:0001891) |
1.6 | 4.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
1.2 | 3.5 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
1.1 | 15.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.0 | 3.0 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.0 | 12.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.9 | 3.6 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.9 | 2.6 | GO:0072487 | MSL complex(GO:0072487) |
0.8 | 8.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.8 | 2.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.8 | 7.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.8 | 8.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.8 | 1.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.8 | 4.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.8 | 1.5 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.7 | 3.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.7 | 3.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.7 | 3.6 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.7 | 0.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.7 | 2.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.7 | 2.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.7 | 1.4 | GO:0005657 | replication fork(GO:0005657) |
0.7 | 2.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.7 | 2.6 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.7 | 3.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.7 | 1.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.7 | 3.9 | GO:0000791 | euchromatin(GO:0000791) |
0.6 | 1.3 | GO:0032449 | CBM complex(GO:0032449) |
0.6 | 6.9 | GO:0045120 | pronucleus(GO:0045120) |
0.6 | 0.6 | GO:0044422 | organelle part(GO:0044422) |
0.6 | 2.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.6 | 10.1 | GO:0005844 | polysome(GO:0005844) |
0.6 | 3.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.6 | 1.8 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.6 | 8.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.6 | 0.6 | GO:0042827 | platelet dense granule(GO:0042827) |
0.6 | 1.7 | GO:0001652 | granular component(GO:0001652) |
0.6 | 3.4 | GO:0005883 | neurofilament(GO:0005883) |
0.6 | 5.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.6 | 6.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.5 | 1.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.5 | 1.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.5 | 6.9 | GO:0043209 | myelin sheath(GO:0043209) |
0.5 | 4.2 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.5 | 9.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.5 | 2.0 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.5 | 1.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 3.4 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.5 | 1.9 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.5 | 2.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.5 | 1.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.5 | 2.9 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.5 | 0.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.5 | 1.4 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.5 | 16.4 | GO:0030175 | filopodium(GO:0030175) |
0.5 | 1.4 | GO:0030891 | VCB complex(GO:0030891) |
0.5 | 7.9 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.5 | 0.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.5 | 14.3 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.5 | 1.8 | GO:0043296 | apical junction complex(GO:0043296) |
0.5 | 1.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.5 | 0.5 | GO:0030496 | midbody(GO:0030496) |
0.4 | 0.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.4 | 9.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 4.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 1.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.4 | 1.3 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.4 | 4.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 0.4 | GO:0044309 | neuron spine(GO:0044309) |
0.4 | 2.1 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.4 | 1.2 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.4 | 1.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 1.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 3.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.4 | 1.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.4 | 8.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.4 | 2.0 | GO:0000796 | condensin complex(GO:0000796) |
0.4 | 0.8 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 1.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 1.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 2.4 | GO:0001741 | XY body(GO:0001741) |
0.4 | 1.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.4 | 2.8 | GO:0034451 | centriolar satellite(GO:0034451) |
0.4 | 2.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 0.4 | GO:0012505 | endomembrane system(GO:0012505) |
0.4 | 47.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.4 | 3.8 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.4 | 3.0 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.4 | 1.1 | GO:0016589 | NURF complex(GO:0016589) |
0.4 | 3.7 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.4 | 5.5 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.4 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 0.7 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.4 | 0.7 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.4 | 2.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 1.1 | GO:0005884 | actin filament(GO:0005884) |
0.4 | 1.1 | GO:0032009 | early phagosome(GO:0032009) |
0.4 | 1.4 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.3 | 7.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.3 | 4.2 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 1.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 2.1 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 1.0 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 2.7 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.3 | 5.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 1.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 1.0 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 1.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 1.3 | GO:0001740 | Barr body(GO:0001740) |
0.3 | 2.0 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.3 | 1.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) contractile ring(GO:0070938) |
0.3 | 1.0 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 4.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.3 | 1.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 1.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 2.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.3 | 0.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 1.9 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.3 | 5.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.3 | 0.9 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 3.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.3 | 16.0 | GO:0016605 | PML body(GO:0016605) |
0.3 | 9.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 1.5 | GO:0070695 | FHF complex(GO:0070695) |
0.3 | 0.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 1.5 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 14.1 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 2.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.3 | 2.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 6.2 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.3 | 0.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 2.9 | GO:0008278 | cohesin complex(GO:0008278) |
0.3 | 1.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.3 | 3.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 12.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 28.2 | GO:0016607 | nuclear speck(GO:0016607) |
0.3 | 2.8 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.3 | 14.5 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.3 | 0.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 2.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.3 | 0.3 | GO:0032059 | bleb(GO:0032059) |
0.3 | 3.0 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 0.5 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.3 | 0.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 1.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 2.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 9.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 2.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 1.3 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.3 | 1.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.3 | 0.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 1.8 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.3 | 1.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 0.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 0.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.3 | 10.1 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.3 | 2.8 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.3 | 1.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.3 | 0.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 15.9 | GO:0000785 | chromatin(GO:0000785) |
0.3 | 1.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 1.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 2.0 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 7.7 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 19.3 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 4.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 2.6 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.2 | 3.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 18.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 0.5 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 1.0 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.5 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.2 | 0.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.2 | 2.6 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 19.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 4.0 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 1.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 3.9 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 0.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.2 | 1.6 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 0.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 0.9 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.2 | 1.3 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.2 | 6.7 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.2 | 0.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 1.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 1.5 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.2 | 0.2 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.2 | 0.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 8.7 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 1.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 1.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 1.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 1.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.2 | 0.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 1.0 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 0.6 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.2 | 3.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 1.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 1.0 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 0.6 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 1.0 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.2 | 8.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.2 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 0.6 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 2.8 | GO:0000123 | histone acetyltransferase complex(GO:0000123) protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.2 | 8.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 0.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 0.9 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.2 | 1.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 4.0 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.2 | 2.3 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.2 | 4.0 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.2 | 2.2 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 0.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.4 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.2 | 0.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 83.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 1.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 1.7 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.2 | 0.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 0.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 112.6 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 0.8 | GO:0031672 | A band(GO:0031672) |
0.2 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 2.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 2.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 40.2 | GO:0005768 | endosome(GO:0005768) |
0.2 | 18.1 | GO:0005840 | ribosome(GO:0005840) |
0.2 | 1.6 | GO:0042597 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.2 | 0.2 | GO:0044304 | main axon(GO:0044304) |
0.2 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 0.5 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 0.8 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 0.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 9.1 | GO:0019867 | outer membrane(GO:0019867) |
0.2 | 9.5 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.2 | 0.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 0.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 422.3 | GO:0005634 | nucleus(GO:0005634) |
0.2 | 2.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 0.9 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.3 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.9 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 4.6 | GO:0098552 | side of membrane(GO:0098552) |
0.1 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 1.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 1.5 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 4.9 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 2.0 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.1 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 1.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 1.6 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 57.5 | GO:0042175 | endoplasmic reticulum membrane(GO:0005789) nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.1 | 22.6 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.1 | 1.8 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 103.8 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 11.9 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.6 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 2.3 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 48.8 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 9.5 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 1.6 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.1 | 2.5 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 1.6 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 8.6 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 1.4 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 1.5 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 2.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 9.6 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.1 | 0.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.5 | GO:0030426 | growth cone(GO:0030426) site of polarized growth(GO:0030427) |
0.1 | 11.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.2 | GO:0005792 | obsolete microsome(GO:0005792) |
0.1 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.4 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 4.9 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 0.7 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.1 | 0.5 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 193.2 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.4 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 2.5 | GO:0044432 | endoplasmic reticulum part(GO:0044432) |
0.1 | 0.3 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.5 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.1 | GO:1902494 | catalytic complex(GO:1902494) |
0.0 | 0.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.5 | GO:0030424 | axon(GO:0030424) |
0.0 | 2.1 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 1.9 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 34.1 | GO:0005622 | intracellular(GO:0005622) |
0.0 | 0.1 | GO:0098796 | membrane protein complex(GO:0098796) |
0.0 | 0.2 | GO:0032994 | protein-lipid complex(GO:0032994) plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.0 | 0.1 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
2.2 | 6.7 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
2.1 | 6.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.0 | 5.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.9 | 27.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
1.7 | 6.8 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.6 | 3.3 | GO:0004527 | exonuclease activity(GO:0004527) |
1.6 | 16.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.4 | 4.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.4 | 4.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
1.3 | 4.0 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
1.3 | 9.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.3 | 3.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.2 | 11.0 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
1.2 | 6.0 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
1.1 | 3.3 | GO:0033691 | sialic acid binding(GO:0033691) |
1.1 | 6.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
1.0 | 3.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.0 | 2.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.0 | 12.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.9 | 3.8 | GO:0015925 | galactosidase activity(GO:0015925) |
0.9 | 8.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.9 | 6.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.9 | 2.6 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.9 | 2.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.9 | 2.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.9 | 3.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.9 | 9.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.8 | 5.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.8 | 2.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.8 | 2.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.8 | 2.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.8 | 19.1 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.8 | 11.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.8 | 3.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.8 | 1.6 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.8 | 2.4 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.8 | 3.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.7 | 9.7 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.7 | 26.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.7 | 5.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.7 | 11.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.7 | 0.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.7 | 2.1 | GO:0005113 | patched binding(GO:0005113) |
0.7 | 13.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.7 | 2.0 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.7 | 2.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.7 | 5.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.7 | 0.7 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) peptide-transporting ATPase activity(GO:0015440) |
0.7 | 3.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.7 | 2.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.7 | 4.6 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.7 | 4.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.6 | 1.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.6 | 4.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.6 | 1.3 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.6 | 3.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.6 | 5.0 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.6 | 0.6 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.6 | 1.9 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.6 | 3.1 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.6 | 3.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.6 | 1.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.6 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.6 | 5.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.6 | 28.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.6 | 2.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.6 | 0.6 | GO:0035197 | siRNA binding(GO:0035197) |
0.6 | 3.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.6 | 8.9 | GO:0043621 | protein self-association(GO:0043621) |
0.6 | 1.8 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.6 | 1.8 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.6 | 1.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.6 | 2.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.6 | 3.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.6 | 4.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.6 | 0.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.6 | 3.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.6 | 6.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.6 | 9.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 2.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.5 | 1.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.5 | 7.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.5 | 1.6 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.5 | 1.6 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.5 | 2.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.5 | 5.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.5 | 28.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.5 | 2.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 4.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.5 | 5.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.5 | 3.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.5 | 2.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.5 | 2.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.5 | 3.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.5 | 1.5 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.5 | 3.0 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.5 | 2.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.5 | 2.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.5 | 1.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.5 | 1.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.5 | 1.5 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.5 | 2.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.5 | 11.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.5 | 16.2 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.5 | 1.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.5 | 2.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.5 | 0.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.5 | 1.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.5 | 13.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.5 | 1.4 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.5 | 1.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 2.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.5 | 3.7 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.5 | 1.4 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.4 | 1.8 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.4 | 4.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.4 | 1.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 1.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.4 | 2.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 3.5 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 1.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.4 | 0.4 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.4 | 4.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.4 | 3.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.4 | 1.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.4 | 1.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.4 | 3.4 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.4 | 1.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 5.5 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.4 | 2.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.4 | 3.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 1.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.4 | 4.6 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.4 | 0.8 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.4 | 1.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 2.5 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.4 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 2.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 0.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 1.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.4 | 0.8 | GO:0008238 | exopeptidase activity(GO:0008238) |
0.4 | 2.4 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.4 | 1.6 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.4 | 0.8 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.4 | 10.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.4 | 4.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.4 | 1.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 1.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.4 | 1.2 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.4 | 4.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 3.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.4 | 2.7 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.4 | 1.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.4 | 1.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.4 | 3.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.4 | 6.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.4 | 2.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 1.1 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.4 | 3.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.4 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.4 | 0.4 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.4 | 4.1 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.4 | 4.8 | GO:0043022 | ribosome binding(GO:0043022) |
0.4 | 0.7 | GO:0060229 | lipase activator activity(GO:0060229) lipoprotein lipase activator activity(GO:0060230) |
0.4 | 0.7 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.4 | 2.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 2.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.4 | 1.8 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.4 | 1.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 1.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 1.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 2.5 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.4 | 0.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.4 | 3.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.4 | 0.4 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.4 | 1.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 2.5 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.4 | 0.4 | GO:0019956 | chemokine binding(GO:0019956) |
0.4 | 4.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 1.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.3 | 1.4 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.3 | 1.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 1.0 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 10.0 | GO:0003823 | antigen binding(GO:0003823) |
0.3 | 2.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.3 | 4.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 1.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 0.3 | GO:0035173 | histone kinase activity(GO:0035173) |
0.3 | 5.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 1.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 4.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 2.7 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.3 | 3.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.3 | 0.7 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.3 | 3.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 4.3 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.3 | 1.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 0.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.3 | 1.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.3 | 1.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 1.3 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.3 | 0.3 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.3 | 1.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 0.3 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.3 | 2.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 1.3 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.3 | 5.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.3 | 7.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.3 | 1.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.3 | 2.5 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.3 | 0.6 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.3 | 11.0 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.3 | 0.9 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 0.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 0.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 0.3 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.3 | 0.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.3 | 0.3 | GO:0042806 | fucose binding(GO:0042806) |
0.3 | 0.6 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.3 | 14.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.3 | 2.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 0.9 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 3.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 0.6 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 1.5 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.3 | 1.5 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.3 | 1.8 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.3 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.3 | 1.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 1.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 1.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 0.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 1.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 0.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 0.6 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.3 | 0.9 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.3 | 0.3 | GO:0043398 | HLH domain binding(GO:0043398) |
0.3 | 4.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 3.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 0.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 6.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 1.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.3 | 1.7 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.3 | 1.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 0.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 0.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 31.2 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.3 | 0.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 1.4 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.3 | 0.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 1.4 | GO:0017069 | snRNA binding(GO:0017069) |
0.3 | 5.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.3 | 1.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.3 | 1.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 0.6 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.3 | 1.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 1.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 1.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 1.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 0.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 1.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.3 | 0.8 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.3 | 1.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 4.0 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.3 | 0.8 | GO:0016208 | AMP binding(GO:0016208) |
0.3 | 9.8 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.3 | 6.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 0.8 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.3 | 8.2 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.3 | 0.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 1.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.3 | 1.0 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.3 | 0.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 6.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 3.0 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.3 | 3.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 3.2 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.2 | 0.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 3.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 2.0 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 1.5 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.2 | 1.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 1.2 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.2 | 0.7 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 0.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 2.4 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.2 | 1.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 1.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 1.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 0.7 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.2 | 3.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 1.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.7 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 10.2 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 2.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 0.2 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.2 | 0.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 0.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 0.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 2.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 0.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 0.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 7.2 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.2 | 2.8 | GO:0005048 | signal sequence binding(GO:0005048) |
0.2 | 3.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 4.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.2 | 0.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 1.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 3.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.7 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.2 | 0.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 2.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.7 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 0.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 4.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 1.1 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.2 | 0.4 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 4.7 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 1.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 0.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.9 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 4.1 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 5.7 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.2 | 1.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 16.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 0.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 4.6 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.2 | 0.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.2 | 0.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 1.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 132.4 | GO:0003723 | RNA binding(GO:0003723) |
0.2 | 1.5 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 0.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 1.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 0.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 1.9 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.2 | 2.7 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 0.4 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 0.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 8.6 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.2 | 0.6 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.2 | 0.8 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 0.6 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 3.7 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.2 | 1.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.6 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 4.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.8 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.2 | 0.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 3.4 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 2.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 1.0 | GO:0015923 | mannosidase activity(GO:0015923) |
0.2 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.8 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 2.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 1.2 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.2 | 1.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 1.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 7.9 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 56.9 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 13.6 | GO:0003682 | chromatin binding(GO:0003682) |
0.2 | 0.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 2.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.6 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.2 | 2.6 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.2 | 1.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.6 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 1.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 1.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 3.2 | GO:0004386 | helicase activity(GO:0004386) |
0.2 | 9.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.9 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 1.1 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.2 | 0.7 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 0.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.4 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.2 | 0.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 0.2 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.2 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 2.1 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 0.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.3 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.2 | 0.3 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.2 | 0.7 | GO:0051192 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.2 | 1.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 0.5 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.2 | 2.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 25.4 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.2 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.5 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.2 | 1.7 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.2 | 0.7 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 3.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 13.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 0.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 1.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 3.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 3.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.3 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.2 | 1.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 0.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 0.8 | GO:0016595 | glutamate binding(GO:0016595) |
0.2 | 1.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 0.5 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.2 | 1.4 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.2 | 1.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 1.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 0.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 0.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 0.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 222.2 | GO:0003677 | DNA binding(GO:0003677) |
0.2 | 5.2 | GO:0044389 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.2 | 4.9 | GO:0008134 | transcription factor binding(GO:0008134) |
0.2 | 0.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 0.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 27.6 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 7.5 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.4 | GO:0030371 | translation repressor activity(GO:0030371) translation regulator activity(GO:0045182) |
0.1 | 3.2 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 1.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.6 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.1 | 0.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.3 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 0.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 1.9 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 0.6 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 2.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.8 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 3.9 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.4 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.6 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.5 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.1 | 1.0 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 2.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 1.9 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.1 | 0.1 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.1 | 0.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 32.4 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 3.5 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.1 | 0.6 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 1.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 0.5 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.5 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 4.4 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 9.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.6 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.4 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 7.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.1 | 1.5 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 1.3 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.2 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.1 | 0.3 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.3 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 2.0 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 1.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.5 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.1 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 3.3 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 16.0 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.7 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 2.0 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.1 | 5.1 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 0.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.9 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 1.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 1.1 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 1.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.6 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 1.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 2.1 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.8 | GO:0043176 | amine binding(GO:0043176) |
0.1 | 1.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.3 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 2.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.1 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.8 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 1.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 1.0 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 2.0 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.1 | 1.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 2.5 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) |
0.1 | 0.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.6 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 14.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 1.4 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 1.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.1 | GO:0005035 | death receptor activity(GO:0005035) |
0.1 | 0.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 0.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.1 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.3 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 1.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.2 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.4 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.4 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 1.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.4 | GO:0032561 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.1 | 0.6 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 1.1 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.7 | GO:0008144 | drug binding(GO:0008144) |
0.0 | 0.4 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 3.4 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 6.4 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.3 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 0.0 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 18.2 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 2.4 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.1 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.2 | GO:0016775 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.0 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.0 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.0 | 0.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.1 | GO:0080032 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 9.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
0.0 | 0.9 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 3.0 | GO:0070011 | peptidase activity, acting on L-amino acid peptides(GO:0070011) |
0.0 | 1.1 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.0 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.0 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.0 | 0.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.0 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0030552 | cAMP binding(GO:0030552) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 87.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.4 | 35.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.2 | 19.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.0 | 5.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.0 | 39.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.9 | 9.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.8 | 32.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.8 | 4.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.8 | 14.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.7 | 16.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.7 | 0.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.6 | 11.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.6 | 9.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.6 | 8.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.6 | 11.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.6 | 8.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.6 | 1.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.6 | 8.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.6 | 8.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.6 | 5.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.6 | 0.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.6 | 14.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.6 | 4.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.5 | 1.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.5 | 15.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.5 | 19.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.5 | 5.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 12.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.5 | 3.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 8.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 8.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.5 | 8.3 | PID MYC PATHWAY | C-MYC pathway |
0.5 | 3.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 3.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.4 | 8.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 9.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.4 | 4.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.4 | 0.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.4 | 9.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.4 | 12.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.4 | 1.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 3.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 10.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 2.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.3 | 4.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 12.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 4.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 1.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 2.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 3.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 4.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 1.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 5.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 3.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 3.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 0.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 12.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 3.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 1.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 1.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 3.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 0.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 3.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 0.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 2.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 4.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 0.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 2.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 1.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 4.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 2.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 3.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 8.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 2.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 2.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 4.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 8.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 1.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 0.9 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 6.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 5.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 4.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 1.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 1.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 2.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 3.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 2.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 1.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 4.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 2.9 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 2.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.9 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 1.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 2.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.6 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 1.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 2.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
2.0 | 22.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
1.8 | 39.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.8 | 7.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.7 | 5.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.4 | 15.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.3 | 1.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
1.1 | 2.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.1 | 15.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.0 | 12.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.0 | 22.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.8 | 22.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.8 | 21.3 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.8 | 7.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.8 | 17.4 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.7 | 9.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.7 | 9.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.7 | 5.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.7 | 18.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.7 | 5.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.6 | 26.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.6 | 2.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.6 | 11.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.6 | 13.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.6 | 8.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.6 | 16.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.6 | 1.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.6 | 6.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.6 | 29.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.6 | 0.6 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.5 | 8.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.5 | 2.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.5 | 9.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.5 | 6.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.5 | 1.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.5 | 6.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.5 | 11.5 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.5 | 1.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.5 | 2.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.5 | 2.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.5 | 1.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.5 | 1.8 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.4 | 2.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.4 | 4.0 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.4 | 1.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.4 | 8.9 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.4 | 1.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.4 | 0.4 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.4 | 4.6 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.4 | 5.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.4 | 7.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.4 | 1.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.4 | 1.6 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.4 | 0.8 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.4 | 4.8 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.4 | 5.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.4 | 0.8 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.4 | 3.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.4 | 7.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 5.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 5.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.4 | 4.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.4 | 1.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 5.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 3.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 1.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 3.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 5.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 30.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 9.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.3 | 22.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 10.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 0.3 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.3 | 14.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.3 | 5.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 6.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 18.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.3 | 6.3 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.3 | 1.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.3 | 0.9 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.3 | 3.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 2.3 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.3 | 2.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 1.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 2.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 3.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 5.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.3 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 0.5 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.3 | 3.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.3 | 5.6 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.3 | 1.6 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.3 | 5.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.3 | 2.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.3 | 2.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 3.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 28.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 2.2 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.2 | 8.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 1.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 3.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 5.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 2.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 0.2 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.2 | 7.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 1.8 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 28.3 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 19.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 8.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 0.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 0.2 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.2 | 9.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 3.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 3.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 5.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 1.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 9.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 2.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.2 | 1.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 2.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 2.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 0.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 2.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 6.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 0.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 1.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 1.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 3.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 1.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 0.9 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 5.5 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.2 | 1.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 2.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 0.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 0.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 2.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 4.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 1.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 1.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 1.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 0.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 10.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 4.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 1.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 1.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 1.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 6.0 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 2.6 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.1 | 0.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 2.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 5.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 2.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 2.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 2.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 1.1 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.4 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.1 | REACTOME S PHASE | Genes involved in S Phase |
0.1 | 1.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.6 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 2.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.2 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 2.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.3 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.1 | 26.8 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 2.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 1.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.4 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 1.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 2.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 2.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.5 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.5 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.1 | 1.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.6 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 0.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 2.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 1.2 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 1.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 6.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 2.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.1 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 1.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 1.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 7.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |